(Q42953783)
Statements
High-risk myeloma: a gene expression based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone (English)
George Mulligan
John D Shaughnessy
Bart Barlogie
1 January 2008